Atlas Trials

Long-Term Effect of 10 mg Versus 20 mg Rimonabant in Overweight or Obese Patients

Clinical trial NCT00678483 · TERMINATED

Trial details

NCT number
NCT00678483
Sponsor
Sanofi
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
ObesityWeight Loss
Start date
2008-04-01
Primary completion
2008-11-01
Enrollment
331

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.